Boston Scientific Can’t Nix $275M Merger With Device Maker

The Delaware chancellor ruled Wednesday that Boston Scientific Corp. failed to show that Channel Medsystems Inc. had misrepresented aspects of its business in a way that significantly affected the companies’ $275 million merger, meaning Boston Scientific will have to complete the deal…

Read this piece in its entirety at Law360.


Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s